DE69814467D1 - Verfahren zur prophylaktischen behandlung von mastitis - Google Patents

Verfahren zur prophylaktischen behandlung von mastitis

Info

Publication number
DE69814467D1
DE69814467D1 DE69814467T DE69814467T DE69814467D1 DE 69814467 D1 DE69814467 D1 DE 69814467D1 DE 69814467 T DE69814467 T DE 69814467T DE 69814467 T DE69814467 T DE 69814467T DE 69814467 D1 DE69814467 D1 DE 69814467D1
Authority
DE
Germany
Prior art keywords
mastitis
prophylactic treatment
prophylactic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69814467T
Other languages
English (en)
Inventor
Ake Lignell
Johan Inborr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astareal AB
Original Assignee
Astacarotene AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene AB filed Critical Astacarotene AB
Application granted granted Critical
Publication of DE69814467D1 publication Critical patent/DE69814467D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69814467T 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis Expired - Lifetime DE69814467D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis

Publications (1)

Publication Number Publication Date
DE69814467D1 true DE69814467D1 (de) 2003-06-12

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69814467T Expired - Lifetime DE69814467D1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis

Country Status (12)

Country Link
US (1) US6335015B1 (de)
EP (1) EP1049460B1 (de)
JP (1) JP2002508318A (de)
AR (1) AR017877A1 (de)
AT (1) ATE239457T1 (de)
AU (1) AU743198B2 (de)
CA (1) CA2314170C (de)
DE (1) DE69814467D1 (de)
NO (1) NO327301B1 (de)
NZ (1) NZ504801A (de)
SE (1) SE511237C2 (de)
WO (1) WO1999030701A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1532108B1 (de) 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthinester zur vermeidung und verbesserung von krankheiten
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2006034570A1 (en) 2004-09-28 2006-04-06 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
WO2006039685A2 (en) * 2004-10-01 2006-04-13 Hawaii Biotech, Inc. Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives
AU2008316225B2 (en) 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
CA3168140A1 (en) * 2020-02-18 2021-08-26 Avivagen Inc. Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
AU4715796A (en) 1995-02-03 1996-08-21 Basf Aktiengesellschaft Use of carotinoids for preparing medicaments for treating dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
NO20003042D0 (no) 2000-06-14
SE9704693L (sv) 1999-06-17
NO327301B1 (no) 2009-06-02
NZ504801A (en) 2002-05-31
ATE239457T1 (de) 2003-05-15
AR017877A1 (es) 2001-10-24
CA2314170A1 (en) 1999-06-24
WO1999030701A1 (en) 1999-06-24
JP2002508318A (ja) 2002-03-19
US6335015B1 (en) 2002-01-01
SE511237C2 (sv) 1999-08-30
SE9704693D0 (sv) 1997-12-16
EP1049460A1 (de) 2000-11-08
AU1897299A (en) 1999-07-05
AU743198B2 (en) 2002-01-24
EP1049460B1 (de) 2003-05-07
NO20003042L (no) 2000-06-14
CA2314170C (en) 2008-01-29

Similar Documents

Publication Publication Date Title
DE69814467D1 (de) Verfahren zur prophylaktischen behandlung von mastitis
DE69806970T2 (de) Verfahren zur behandlung von hartgeweben
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE69624116D1 (de) Verfahren zur behandlung von allergischem asthma
DE69701714T2 (de) Verfahren zur behandlung von glassubstraten
DE69710422D1 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
ATE257189T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE69702997D1 (de) Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE69937624D1 (de) Verfahren zur Behandlung von Metalloberflächen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE69834578D1 (de) Verfahren zur behandlung von zementaufschlämmungen
DE60021948D1 (de) Verfahren zur Behandlung von Kontaktlinsen
DE69626311T2 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69810449D1 (de) Verfahren zur behandlung von keimblättrigen pflanzen
DE69706758D1 (de) Verfahren zur Behandlung von Polyolefin
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69802904D1 (de) Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
ATE307871T1 (de) Verfahren zur behandlung von gewebe
DE69905263T2 (de) Verfahren zur dekorativen behandlung von oberflächen
DE69701726D1 (de) Verfahren zur behandlung von knitterempfindlichen geweben
DE60021022D1 (de) Verfahren zur Behandlung von Purinen
DE60034093D1 (de) Verfahren zur Behandlung von Kieselsäuren enthaltenden Schlamm

Legal Events

Date Code Title Description
8332 No legal effect for de